\-\ Texto\\:\\ \ \(0\)\
\-\ not\\ entered\ \(0\)\
\-\ she\\ was\\ referred\\ to\\ radiology\\ for\\ followup\\ evaluation\\ and\\ subsequent\\ ct\\-guided\\ biopsy\\ of\\ the\\ liver\\ lesion\\.\ \(0\)\
\-\ suspicious\\ metastases\\ in\\ the\\ liver\\,\\ lungs\\,\\ and\\ bone\\.\\ biopsy\\ from\\ liver\\.\ \(0\)\
\-\ \\(\\#56\\)\\ 3\\.3\\ x\\ 3\\.2\\ cm\\ heterogeneous\\ mass\\ seen\\ in\\ posterior\\ right\\ lobe\\ of\\ liver\\.\\ \ \(1\)\
\-\ \\(\\#59\\)\\ additional\\ 3\\.3\\ x\\ 2\\.7\\ cm\\ heterogeneous\\ mass\\ seen\\ in\\ posterior\\ right\\ lobe\\ of\\ liver\\.\ \(0\)\
\-\ \\(\\#66\\)\\ additional\\ 1\\.6\\ cm\\ diameter\\ heterogeneous\\ mass\\ seen\\ in\\ posterior\\ right\\ lobe\\ of\\ liver\\ close\\ to\\ parenchymal\\ edge\\.\ \(0\)\
\-\ \\(\\#23\\,\\ \\#28\\,\\ \\#35\\)\\ numerous\\ lung\\ nodules\\ on\\ bilateral\\ lung\\ fields\\.\ \(0\)\
\-\ \\(\\#98\\)\\ well\\ defined\\ lucencies\\ noted\\ within\\ right\\ iliac\\ in\\ proximity\\ to\\ sacroiliac\\ joint\\.\ \(1\)\
\-\ liver\\ metastases\\ from\\ breast\\ cancer\ \(0\)\
\-\ metastatic\\ disease\ \(243\)\
\-\ primary\\ neoplasm\ \(4\)\
\-\ cystic\\ mass\ \(109\)\
\-\ 46\\ yo\\ woman\\ with\\ a\\ 15\\ year\\ history\\ of\\ breast\\ cancer\\ referred\\ to\\ radiology\\ for\\ followup\\ evaluation\\.\ \(1\)\
\-\ liver\\ metastases\\ from\\ breast\\ cancer\\ is\\ usually\\ a\\ late\\ finding\\ and\\ as\\ this\\ case\\ indicates\\,\\ possible\\ other\\ metastases\\ have\\ already\\ occurred\\ to\\ other\\ organ\\ systems1\\,2\\.\\ \\ it\\ is\\ therefore\\ essential\\ to\\ have\\ diligent\\ follow\\ up\\ of\\ treated\\ primary\\ breast\\ cancer\\ patients\\.\\ \\ \\ thorough\\ history\\ and\\ physical\\ \\(review\\ of\\ system\\ for\\ systemic\\ recurrence\\,\\ and\\ complete\\ physical\\ looking\\ for\\ locoregional\\ recurrence\\)\\ is\\ recommended\\ every\\ 3\\-6\\ months\\ for\\ the\\ first\\ 3\\ years\\ post\\ primary\\ therapy\\ and\\ then\\ every\\ 6\\-12\\ months\\ for\\ 2\\ years\\ and\\ then\\ annually3\\.\\ \\ mammography\\ should\\ be\\ taken\\ every\\ 6\\ months\\ after\\ radiation\\ treatment\\ if\\ the\\ patient\\ had\\ breast\\ conserving\\ surgical\\ treatment\\.\\ \\ yearly\\ mammography\\ should\\ be\\ taken\\ for\\ those\\ that\\ did\\ not\\ have\\ breast\\ conserving\\ surgery3\\.\\ \\ patients\\ should\\ also\\ conduct\\ monthly\\ breast\\ examinations3\\.\\ \\ pelvic\\ examination\\ should\\ be\\ conducted\\ regularly\\,\\ but\\ could\\ be\\ extended\\ if\\ patient\\ has\\ had\\ total\\ hysterectomy\\ and\\ oophorectomy3\\.\\ \\ if\\ the\\ patient\\ had\\ isolated\\ and\\ single\\ liver\\ metastases\\ then\\ the\\ patient\\ may\\ be\\ a\\ good\\ candidate\\ for\\ surgical\\ resection\\.\\ \\ however\\,\\ due\\ to\\ possibility\\ of\\ extrahepatic\\ lesions\\ and\\ numerous\\ liver\\ metastases\\,\\ the\\ patient\\ in\\ the\\ case\\ is\\ not\\ a\\ good\\ surgical\\ candidate1\\,2\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ liver\\:\\ 0\\.38385946230426093\ \(0\)\
\-\ breast\\:\\ 0\\.2828504658810408\ \(0\)\
\-\ metastases\\:\\ 0\\.2699114368379683\ \(0\)\
\-\ conserving\\:\\ 0\\.16445155434523553\ \(0\)\
\-\ every\\:\\ 0\\.1616897840695616\ \(0\)\
\-\ cancer\\:\\ 0\\.14825190674185174\ \(0\)\
\-\ should\\:\\ 0\\.14523136775105916\ \(0\)\
\-\ for\\:\\ 0\\.1349226581086944\ \(0\)\
\-\ heterogeneous\\:\\ 0\\.12082211321268962\ \(0\)\
\-\ then\\:\\ 0\\.11816854056338741\ \(0\)\
\-\ mammography\\:\\ 0\\.11597264767524218\ \(0\)\
\-\ and\\:\\ 0\\.11498194245214008\ \(0\)\
\-\ be\\:\\ 0\\.1128631523881916\ \(0\)\
\-\ primary\\:\\ 0\\.10264555429904411\ \(0\)\
\-\ followup\\:\\ 0\\.09825967271012868\ \(0\)\
\-\ to\\:\\ 0\\.097376598137295\ \(0\)\
\-\ months\\:\\ 0\\.0971682919603588\ \(0\)\
\-\ if\\:\\ 0\\.09699200214501409\ \(0\)\
\-\ lobe\\:\\ 0\\.09646941645712283\ \(0\)\
\-\ cm\\:\\ 0\\.09587129886010759\ \(0\)\
\-\ numerous\\:\\ 0\\.09400490296095868\ \(0\)\
\-\ recurrence\\:\\ 0\\.09188358920384225\ \(0\)\
\-\ good\\:\\ 0\\.09051394994421579\ \(0\)\
\-\ patient\\:\\ 0\\.09049133660367276\ \(0\)\
\-\ radiology\\:\\ 0\\.08913123784337607\ \(0\)\
\-\ annually3\\:\\ 0\\.08898720168685485\ \(0\)\
\-\ surgery3\\:\\ 0\\.08898720168685485\ \(0\)\
\-\ examinations3\\:\\ 0\\.08898720168685485\ \(0\)\
\-\ oophorectomy3\\:\\ 0\\.08898720168685485\ \(0\)\
\-\ taken\\:\\ 0\\.08892694961829387\ \(0\)\
\-\ the\\:\\ 0\\.08882428528055626\ \(0\)\
\-\ of\\:\\ 0\\.08711460103081684\ \(0\)\
\-\ posterior\\:\\ 0\\.08632229904707085\ \(0\)\
\-\ additional\\:\\ 0\\.08627109975993898\ \(0\)\
\-\ locoregional\\:\\ 0\\.0850320218945694\ \(0\)\
\-\ conduct\\:\\ 0\\.0850320218945694\ \(0\)\
\-\ mass\\:\\ 0\\.08501840743086334\ \(0\)\
\-\ have\\:\\ 0\\.08339200156340089\ \(0\)\
\-\ had\\:\\ 0\\.0831719702948834\ \(0\)\
\-\ in\\:\\ 0\\.08305483776251751\ \(0\)\
\-\ referred\\:\\ 0\\.0823480854343193\ \(0\)\
\-\ diligent\\:\\ 0\\.08222577717261777\ \(0\)\
\-\ surgical\\:\\ 0\\.08113469998525764\ \(0\)\
\-\ seen\\:\\ 0\\.0785905271539206\ \(0\)\
\-\ biopsy\\:\\ 0\\.07800921089491338\ \(0\)\
\-\ entered\\:\\ 0\\.07431541758804687\ \(0\)\
\-\ right\\:\\ 0\\.07379342854305683\ \(0\)\
\-\ monthly\\:\\ 0\\.07150917286609525\ \(0\)\
\-\ regularly\\:\\ 0\\.07000548329669044\ \(0\)\
\-\ thorough\\:\\ 0\\.0693324803535022\ \(0\)\
\-\ years\\:\\ 0\\.06821830932272752\ \(0\)\
\-\ evaluation\\:\\ 0\\.06786991886413335\ \(0\)\
\-\ lung\\:\\ 0\\.06769802923033101\ \(0\)\
\-\ from\\:\\ 0\\.06629856053468225\ \(0\)\
\-\ proximity\\:\\ 0\\.066050303504405\ \(0\)\
\-\ not\\:\\ 0\\.06590102853757819\ \(0\)\
\-\ yearly\\:\\ 0\\.06559651593527378\ \(0\)\
\-\ sacroiliac\\:\\ 0\\.06474774835185816\ \(0\)\
\-\ hysterectomy\\:\\ 0\\.06474774835185816\ \(0\)\
\-\ conducted\\:\\ 0\\.06434954311895752\ \(0\)\
\-\ extrahepatic\\:\\ 0\\.06396695786315913\ \(0\)\
\-\ patients\\:\\ 0\\.06260581987882427\ \(0\)\
\-\ essential\\:\\ 0\\.06225120181969923\ \(0\)\
\-\ looking\\:\\ 0\\.06225120181969923\ \(0\)\
\-\ is\\:\\ 0\\.060954177162904875\ \(0\)\
\-\ candidate\\:\\ 0\\.06079256855957273\ \(0\)\
\-\ physical\\:\\ 0\\.060343133421690745\ \(0\)\
\-\ lucencies\\:\\ 0\\.059288878990167916\ \(0\)\
\-\ already\\:\\ 0\\.05905934666790852\ \(0\)\
\-\ indicates\\:\\ 0\\.05861587604697966\ \(0\)\
\-\ other\\:\\ 0\\.05779386070798757\ \(0\)\
\-\ extended\\:\\ 0\\.05739495043870622\ \(0\)\
\-\ organ\\:\\ 0\\.05720553334892205\ \(0\)\
\-\ edge\\:\\ 0\\.05614032989670145\ \(0\)\
\-\ case\\:\\ 0\\.055910089608532096\ \(0\)\
\-\ fields\\:\\ 0\\.05473322204318219\ \(0\)\
\-\ 98\\:\\ 0\\.053896594689853874\ \(0\)\
\-\ occurred\\:\\ 0\\.053763875994716416\ \(0\)\
\-\ treatment\\:\\ 0\\.05301257728525098\ \(0\)\
\-\ isolated\\:\\ 0\\.05288220897500182\ \(0\)\
\-\ 59\\:\\ 0\\.05276251822653014\ \(0\)\
\-\ late\\:\\ 0\\.05252745447593084\ \(0\)\
\-\ 66\\:\\ 0\\.052185150104416\ \(0\)\
\-\ 56\\:\\ 0\\.051963443433291144\ \(0\)\
\-\ possibility\\:\\ 0\\.0517466639872318\ \(0\)\
\-\ iliac\\:\\ 0\\.05122489932338402\ \(0\)\
\-\ 46\\:\\ 0\\.05112381371809978\ \(0\)\
\-\ close\\:\\ 0\\.050350761963337785\ \(0\)\
\-\ parenchymal\\:\\ 0\\.04998605879067009\ \(0\)\
\-\ suspicious\\:\\ 0\\.04972120975397921\ \(0\)\
\-\ systemic\\:\\ 0\\.049378905382464366\ \(0\)\
\-\ therefore\\:\\ 0\\.04904820681079096\ \(0\)\
\-\ those\\:\\ 0\\.04761444351657\ \(0\)\
\-\ 28\\:\\ 0\\.046181185109573406\ \(0\)\
\-\ 23\\:\\ 0\\.045882853796517756\ \(0\)\
\-\ review\\:\\ 0\\.04582426699208034\ \(0\)\
\-\ total\\:\\ 0\\.04559337636394726\ \(0\)\
\-\ diameter\\:\\ 0\\.044720868993647675\ \(0\)\
\-\ 35\\:\\ 0\\.04461709489135994\ \(0\)\
\-\ recommended\\:\\ 0\\.04426234039228896\ \(0\)\
\-\ nodules\\:\\ 0\\.04421269818023427\ \(0\)\
\-\ pelvic\\:\\ 0\\.04349687539553418\ \(0\)\
\-\ single\\:\\ 0\\.042787131641995636\ \(0\)\
\-\ history\\:\\ 0\\.04251861715215571\ \(0\)\
\-\ system\\:\\ 0\\.04245073025015626\ \(0\)\
\-\ subsequent\\:\\ 0\\.042125544350918934\ \(0\)\
\-\ lungs\\:\\ 0\\.04106585668828044\ \(0\)\
\-\ could\\:\\ 0\\.04047448328936556\ \(0\)\
\-\ did\\:\\ 0\\.03991692161794661\ \(0\)\
\-\ defined\\:\\ 0\\.039696289545954326\ \(0\)\
\-\ complete\\:\\ 0\\.03900460544745669\ \(0\)\
\-\ neoplasm\\:\\ 0\\.03798556142571076\ \(0\)\
\-\ possible\\:\\ 0\\.037702050294909854\ \(0\)\
\-\ 15\\:\\ 0\\.03760096468962562\ \(0\)\
\-\ first\\:\\ 0\\.037550812015569396\ \(0\)\
\-\ radiation\\:\\ 0\\.03687447471117416\ \(0\)\
\-\ joint\\:\\ 0\\.03666667498922869\ \(0\)\
\-\ finding\\:\\ 0\\.036575721662541034\ \(0\)\
\-\ resection\\:\\ 0\\.03566866091632744\ \(0\)\
\-\ examination\\:\\ 0\\.035606987326590185\ \(0\)\
\-\ usually\\:\\ 0\\.03503009031957193\ \(0\)\
\-\ yo\\:\\ 0\\.034763344341987495\ \(0\)\
\-\ treated\\:\\ 0\\.03465122042227058\ \(0\)\
\-\ cystic\\:\\ 0\\.03351261322332613\ \(0\)\
\-\ she\\:\\ 0\\.03312367106041712\ \(0\)\
\-\ however\\:\\ 0\\.032934865031717254\ \(0\)\
\-\ due\\:\\ 0\\.03198533313791101\ \(0\)\
\-\ therapy\\:\\ 0\\.03197120616423836\ \(0\)\
\-\ lesions\\:\\ 0\\.031957099620035866\ \(0\)\
\-\ metastatic\\:\\ 0\\.030518064296376567\ \(0\)\
\-\ bone\\:\\ 0\\.03036121396954252\ \(0\)\
\-\ post\\:\\ 0\\.030277789251761753\ \(0\)\
\-\ follow\\:\\ 0\\.029997059845568635\ \(0\)\
\-\ bilateral\\:\\ 0\\.029905250474991606\ \(0\)\
\-\ noted\\:\\ 0\\.02950247737798686\ \(0\)\
\-\ woman\\:\\ 0\\.028979685239431806\ \(0\)\
\-\ it\\:\\ 0\\.028483492124822436\ \(0\)\
\-\ may\\:\\ 0\\.028001919827750413\ \(0\)\
\-\ up\\:\\ 0\\.027525092735365807\ \(0\)\
\-\ but\\:\\ 0\\.027516147596163974\ \(0\)\
\-\ after\\:\\ 0\\.026993917264313595\ \(0\)\
\-\ well\\:\\ 0\\.026943199609595424\ \(0\)\
\-\ lesion\\:\\ 0\\.026677070950613817\ \(0\)\
\-\ also\\:\\ 0\\.026173440517480173\ \(0\)\
\-\ within\\:\\ 0\\.025628006139215856\ \(0\)\
\-\ has\\:\\ 0\\.025416652682663615\ \(0\)\
\-\ that\\:\\ 0\\.02414749934182808\ \(0\)\
\-\ disease\\:\\ 0\\.02335746156299135\ \(0\)\
\-\ as\\:\\ 0\\.022354253015699172\ \(0\)\
\-\ was\\:\\ 0\\.019392557242319988\ \(0\)\
\-\ this\\:\\ 0\\.01912035179184463\ \(0\)\
\-\ year\\:\\ 0\\.017148449232846735\ \(0\)\
\-\ on\\:\\ 0\\.01680550580426232\ \(0\)\
\-\ with\\:\\ 0\\.010895831498021811\ \(0\)\
